.... 2024 Early breast cancer (post)(neo)Adjuvant Breast surgery Reconstruction Radiotherapy Communication Breast cancer is the most frequent cancer in the European Union encountering for >400,000 new cases per year. For women diagnosed with early breast cancer (EBC), the 5-year...

.... Hence, it is of interest to explore alternative treatment strategies for this group of women. Summary: Our narrative review aims to explore two such techniques, cryoablation and external beam radiotherapy, providing a brief summary of the evidence behind each technique. Following this, we discuss which...

... Reconstruction Radiotherapy Communication Breast cancer (BC) is the most frequent cancer in the European Union encountering for >400,000 new cases per year. For women diagnosed with early breast cancer (EBC), the 5-year survival probability is about 96% in Europe [ 1 ]. Optimal management of BC...

...: Between 2015 and 2019, 207 patients with ER+/HER2− pN0-N1 early breast cancer who underwent surgery, EP test, and adjuvant radiotherapy were accrued. The EPclin score, which combines the molecular EP score with nodal status and tumor size, was calculated, and patients were divided into EPclin low- or high...

.... 2022 Early breast cancer Postneoadjuvant therapy Breast surgery Reconstruction Radiotherapy Communication Breast cancer is the most frequent cancer in the European Union, encountering >400,000 new cases per year and thus, the most frequent cancer in women. For women diagnosed...

...Mohamed Abouegylah; Omnia Elemary; Amr Munir; Mohamed Y. Gouda; Waleed O. Arafat; Sherif Elzawawy Purpose: The present study is aiming to correlate different radiotherapy techniques, fractionations, and doses received by each axillary LN level and axillary vessels with the development of breast...

...-associated anaplastic large cell lymphoma reconstruction treatment, and robotic surgery with regard to radiotherapy define innovative standards in the breast reconstruction setting. The role of meshes/acellular dermal matrix and fat grafting as well as optimal sequencing of postmastectomy radiotherapy...

... from any ideas, methods, instructions or products referred to in the content or advertisements. 2021 Early breast cancer Neoadjuvant systemic therapy Adjuvant treatment Endocrine therapy Chemotherapy Breast surgery Axillary surgery Radiotherapy Immunotherapy Survivorship Consensus...

... understood yet, it has been demonstrated that in situ tumor vaccination, and the resulting antitumor immune response, is one of the key factors. Summary: The development of immune therapies has recently led to concepts combining local radiotherapy and immune therapy with the aim of enhancing the response...

...Lidia Kowalczyk; Christine Deutschmann; Richard Crevenna; Stefan Konrad; Christian F. Singer; Alex Farr Background: A large proportion of breast cancer patients who undergo adjuvant radiotherapy suffer from radiotherapy-induced fatigue. The possible causative factors of this specific side effect...

... to the most important contouring guidelines, the European Society for Radiotherapy and Oncology (ESTRO) and the Radiation Therapy and Oncology Group (RTOG). Summary: The use of extensive radiotherapy target volumes (level I, II, III, IV) is probably not necessary for all patients to reproduce the clinical...

... to better estimate the amount of benefit from adjuvant radiotherapy. The rising availability of gene expression analyses prompts the question whether their results can also be used to guide clinical decisions regarding adjuvant radiation. Summary: Multiple studies suggest a correlation between results from...

...: Retrospective analysis of patient data who underwent adjuvant radiotherapy in the period 2009–2018 following breast-conserving surgery and who made use of the recommended radiooncology follow-up examinations in 2018. Analysis was done by descriptive statistics. Results: Of a total of 5,129 patients who had...

... surgery Sentinel node Axillary dissection Radiotherapy Targeted therapy The St. Gallen Consensus Conference 2019 (March 20–23) was held in Vienna, Austria, for the third time. Giuseppe Curigliano and Eric Winer chaired the panel discussion and the voting. Once again, the conference focused...

... cellulitis', without limitations to the dates or the article types, in the PubMed database. Information about the number of cases with DBC, the age of the patients, the interval between the onset of symptoms and the time of surgery or radiotherapy, and the type and outcome of DBC treatment were reviewed...

... the lack of data in the setting of mastectomy. As locoregional radiotherapy has a significant effect on both recurrence and survival, a standardization of locoregional radiotherapy in the situation of SLN biopsy alone in pN1(sn) patients has to be defined in the future, and de-escalation trials should...

...). This paradigm shift is associated with a controversial debate regarding the significance of axillary staging, the need for surgery, and the role of radiotherapy. Looking ahead, lymph node staging and axillary treatment might shift from SLNB and/or axillary dissection to ultrasound-guided needle biopsy...

... subjects of all breast cancer modalities were further de-escalated (surgery: ‘no ink on tumor' clearly confirmed as standard; resection within new limits after neoadjuvant systemic therapy; axillary dissection may also be avoided after mastectomy under certain circumstances; radiotherapy: hypofractionation...

... research, and the consequences of these studies led to clinical trials aimed at assessing whether localized radiotherapy, such as intraoperative radiotherapy (IORT), would be more effective in inhibiting formation of local recurrence than the standard postoperative whole breast radiotherapy. IORT involves...

...% to radiotherapy in the supraclavicular fossa, and 4.3% to axillary radiotherapy. The mean follow-up was 96.7 months. 45 patients (7.2%) developed lymphedema, of which 82.2% had developed lymphedema at 60 months. Univariate regression analysis showed that supraclavicular radiotherapy, adjuvant/palliative...